Skip to main content

Chronic Nonmalignant Pain

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Purdue Pharma
Purdue PharmaCT - Stamford
1 program
1
Buprenorphine transdermal patchPhase 31 trial
Active Trials
NCT01151098Completed189Est. Feb 2002
Flowonix Medical
Flowonix MedicalNJ - Hackettstown
1 program
Flowonix Prometra® II Programmable Infusion SystemN/A1 trial
Active Trials
NCT04096391Completed73Est. Apr 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Purdue PharmaBuprenorphine transdermal patch
Flowonix MedicalFlowonix Prometra® II Programmable Infusion System

Clinical Trials (2)

Total enrollment: 262 patients across 2 trials

NCT01151098Purdue PharmaBuprenorphine transdermal patch

Safety of Buprenorphine Transdermal Systems in Subjects With Chronic Nonmalignant Pain - a 28-week Extension Study

Start: Apr 2001Est. completion: Feb 2002189 patients
Phase 3Completed
NCT04096391Flowonix MedicalFlowonix Prometra® II Programmable Infusion System

Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population

Start: Jun 2019Est. completion: Apr 202273 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.